Chad Lee, PhD

Director of Clinical Development

Chad has over 20 years of expertise in radiation therapy and its clinical implementation. He has been published in many peer-reviewed journals and is certified in Therapeutic Radiological Physics by the American Board of Radiology.

Prior to joining TAE Life Sciences, Chad served as Director of Medical Physics in the Department of Radiation Oncology at Geisinger Health. He led physicists, dosimetrists and physics residents in support of multiple linear accelerator-based, stereotactic radiosurgery and brachytherapy programs.

Chad is an industry leader in treatment planning and training for CyberKnife, and has held roles on parent company Accuray Incorporated’s advisory boards. Chad co-founded CK Solutions, Inc., which became Chad Lee Physics, LLC, to offer cancer centers affordable technical support for the unique demands of CyberKnife. He later served as Senior Director, Global Medical Physics for Accuray, leading both the research and development and physics customer support teams for the CyberKnife and Tomotherapy product lines in the US, Europe, Asia-Pacific and Japan.

Chad holds B.S.E. and M.E. degrees in Nuclear Engineering from the University of Florida, and holds a PhD in Nuclear Engineering from the Massachusetts Institute of Technology, where his thesis research focused on accelerator-based neutron capture therapy. He conducted postdoctoral research at State University, Los Alamos National Laboratory and the University of Maryland.

Have questions about BNCT? Get answers on our new BNCT Forum